Improved survival of patients with acute myocardial infarction with significant left ventricular dysfunction undergoing invasive coronary procedures

American Heart Journal

Volumn 141, Issue 2, 2001, Pages 267-276

  Rott, David ^a   Behar, Solomon ^b   Hod, Hanoch ^b   Feinberg, Micha S ^b   Boyko, Valentina ^b   Mandelzweig, Lori ^b   Kaplinsky, Elieser ^b   Gottlieb, Shmuel ^a,b  

^a BIKUR CHOLIM HOSPITAL   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0035153027     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.111545     Document Type: Article

References (29)

1. Risk stratification after myocardial infarction
2. Guidelines far coronary angiography: Executive summary and recommendations. A report of the ACC/AHA Task Force on Practice Guidelines
3. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Collaboration
4. Coronary Artery Surgery Study (CASS) A randomized trial of coronary artery bypass surgery. Survival data
5. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: Results from the GUSTO-I trial
6. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial: An observational study
7. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators: Should we emergently revascularize occluded coronaries far cardiogenic shock?
8. Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-1 trial experience
9. Argatroban versus heparin as adjuvant therapy for thrombolysis far acute myocardial infarction: Safety considerations ARGAMI-2 study
10. Determination of left ventricular ejection fraction by visual estimation during real-time two-dimensional echocardiography
11. Superiority of visual estimation versus computerized echocardiographic estimation of radionucleotide left ventricular ejection fraction
12. Comparison of different echocardiographic methods with radionucleotide imaging for measuring left ventricular ejection fraction during AMI treated by thrombolytic therapy
13. Risk stratification and survival after myocardial infarction
14. Multivessel coronary artery disease: A key predictor of short term prognosis after reperfusion therapy for acute myocardial infarction: Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group
15. Prediction of mortality following hospital discharge after thrombolysis far acute myocardial infarction: Is there a need for coronary angiography?
16. Continuing evolution of therapy for coronary artery disease: Initial results from the era of coronary angioplasty
17. The evolution of medical and surgical therapy for coronary artery disease: A 15 year perspective
18. SWIFT trial of delayed elective intervention versus conservative treatment after thrombolysis with anistreplase in acute myocardial infarction: SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group
19. Comparison of immediate invasive, delayed invasive and conservative strategies after tissue-type plasminogen activator: Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial
20. The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: Additional information and perspectives
21. Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction
22. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina
23. Randomized trial of late elective angioplasty versus conservative management of myocardial infarction: Treatment of Post Thrombolytic Stenoses (TOPS) Study Group
24. Randomized trial of deferred angioplasty after thrombolysis for acute myocardial infarction
25. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI)
26. Comparison of invasive conservative strategies after treatment with intravenous plasminogen activator in acute myocardial infarction (TIMI) phase II trial
27. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction
28. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: Results from an International Registry